Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences

Audio By Carbonatix

DALLAS--(BUSINESS WIRE)--Nov 3, 2025--

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, will be presenting at 3 upcoming healthcare conferences.

Forte will be presenting at the Guggenheim 2 nd Annual Healthcare Innovation Conference at the InterContinental Boston in Boston MA on Mon, Nov 10 at 3:30-3:55 PM ET.

On Nov. 12 at 2:00-2:20 PM ET, Forte will present at the virtual TD Cowen Immunology and Inflammation Summit.

Additionally on Dec 4 at 11:15-11:35 AM ET, Forte will be presenting at the 8 th Annual Evercore Healthcare Conference in Coral Gables FL at the Loews Hotel.

Source: Forte Biosciences, Inc.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251103872383/en/

CONTACT: LifeSci Advisors

Mike Moyer, Managing Director

[email protected] Biosciences, Inc.

Paul Wagner, CEO

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA TEXAS

INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH

SOURCE: Forte Biosciences, Inc.

Copyright Business Wire 2025.

PUB: 11/03/2025 04:01 PM/DISC: 11/03/2025 04:01 PM

http://www.businesswire.com/news/home/20251103872383/en